Emergence of Vulvovaginal Candidiasis among Lebanese Pregnant Women: Prevalence, Risk Factors, and Species Distribution
Table 2
Candida spp. distribution with regard to patients’ demographic and clinical symptoms.
Variables
C. albicans N (%)
C. glabrata N (%)
C. krusei N (%)
P value
Age group
20 -25
1 (100)
0 (0)
0 (0)
0.7755
26 – 30
6 (42.8)
5 (35.7)
3 (21.5)
31 - 40
10 (55.5)
6 (33.3)
2 (11.2)
Level of education
None
2 (66.7)
1 (33.3)
0 (0)
0.1994
Primary
0 (0)
1 (33.3)
2 (66.7)
Secondary
2 (50)
2 (50)
0 (0)
Tertiary
13 (56.5)
7 (30.4)
3 (13.1)
Clinical Symptoms
Discharge
Yes
8 (44.5)
6 (33.3)
4 (22.2)
0.4293
No
9 (60)
5 (33.3)
1 (6.7)
Itching
Yes
6 (100)
0 (0)
0 (0)
0.0317
No
11 (40.7)
11 (40.7)
5 (18.6)
Malodor
Yes
1 (33.3)
1 (33.3)
1 (33.3)
0.6276
No
16 (53.3)
10 (33.3)
4 (13.4)
N: number of individuals; Chi square test was performed to generate p values for differences in Candida species distribution with regard to age, level of education, and clinical symptoms.
